Author: Bill Snyder
VUMC joins national effort to improve disease prediction in diverse populations
Jun. 16, 2021—Vanderbilt University Medical Center will participate in a new federal initiative aimed at improving the use of polygenic risk scores (PRS) to predict complex diseases in diverse populations.
VUMC team develops potential treatment for life-threatening microbial inflammation
Jun. 8, 2021—A cell-penetrating peptide developed by researchers at Vanderbilt University Medical Center can prevent, in an animal model, the often-fatal septic shock that can result from bacterial and viral infections.
VUMC team discovers new genetic disease
Jun. 3, 2021—Researchers at Vanderbilt University Medical Center have discovered a new genetic disease that causes a severe form of neurogenic orthostatic hypotension, a rapid drop in blood pressure upon standing that can cause fainting.
VUMC researchers receive grant from the National Heart, Lung, and Blood Institute to develop biomarkers to improve the diagnosis of acute heart failure
May. 26, 2021—Researchers at Vanderbilt University Medical Center (VUMC) have received a four-year, $6.2-million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to develop a novel panel of biomarkers to improve the diagnosis of acute heart failure (AHF).
Therapeutic antibodies for hantavirus
May. 24, 2021—Vanderbilt Vaccine Center researchers have isolated monoclonal antibodies against hantaviruses, an emerging source of human disease with pandemic potential.
New clue to lung scarring
May. 20, 2021—Vanderbilt neonatology team pinpoints signaling pathways involved in the progressive lung fibrosis that occurs in rare genetic diseases.
Nominations sought for Vanderbilt Prize Student Scholar
May. 12, 2021—Nominations for the 2021 Vanderbilt Prize Student Scholar are now open. The deadline is June 1.
VUMC to lead national study to treat severe COVID complications
May. 6, 2021—The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.
Faculty Awards honor teaching, research, clinical excellence
May. 6, 2021—The 2021 Vanderbilt University School of Medicine Faculty Awards for Excellence in Teaching, Outstanding Contributions to Research and Extraordinary Performance of Clinical Service were presented April 30 during the annual spring faculty meeting, held virtually this year via Zoom.
Dire need to reform organ procurement rules: Karp
May. 5, 2021—A rule requiring greater accountability from organ procurement organizations (OPOs) will increase the nation’s supply of organs donated for transplantation, but it must be implemented quickly and effectively, Seth Karp, MD, director of the Vanderbilt Transplant Center, testified before Congress on Tuesday, May 4.
Genetic ancestry and hypertension risk
Apr. 29, 2021—Racial disparities in hypertension risk are due in part to genetic differences between ancestries, Vanderbilt investigators find in a study of participants in the Million Veteran Program.
Regev receives Vanderbilt Prize in Biomedical Science
Apr. 28, 2021—Aviv Regev, PhD, an internationally known computational biologist and executive vice president of Genentech Research and Early Development (gRED), is the recipient of the 2021 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center announced this week.
